封面
市場調查報告書
商品編碼
1470777

醫療事務外包市場:按服務、業務模式和最終用戶分類 - 全球預測 2024-2030

Medical Affairs Outsourcing Market by Services, Operational Model, End-User - Global Forecast 2024-2030

出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年醫療事務外包市場規模為97.8億美元,2024年將達111.6億美元,預計2030年將達到253.9億美元,複合年成長率為14.59%。

醫療事務是生命科學產業的一項重要職能,涵蓋了連結臨床開發、商業化以及與醫療保健相關人員互動的廣泛活動。醫學事務外包是指將醫學寫作、醫學傳播、出版策劃、現場醫療參與、醫學資訊服務、衛生經濟學和結果研究(HEOR)等活動委託給具有專業知識點的外部組織。隨著治療方法變得更加複雜,對專業醫療事務服務的需求也增加。進入新市場的公司也會尋求當地醫療事務支持,以因應不同的監管環境。強大的製藥和生技公司通路正在擴大外包服務的可能性。然而,確保資料安全和維持品管等挑戰仍然是主要障礙。尋求開拓市場的製藥公司專注於提高服務合規性和交付,同時制定個人化醫療事務策略以支持個人化治療、展示產品價值並改善臨床結果。醫療事務的數位化和人工智慧也有潛力提供創新的外包服務。

主要市場統計
基準年[2023] 97.8億美元
預測年份 [2024] 111.6億美元
預測年份 [2030] 253.9億美元
複合年成長率(%) 14.59%

服務:擴大採用醫療保健外包來提供策略指導,以應對複雜的監管途徑

使用醫療事務外包進行臨床試驗提交和產品註冊的組織可以獲得整體臨床研究和產品市場進入生命週期的全面支援。這包括準備和提交啟動臨床試驗所需的文件,與監管機構互動以確保所有臨床試驗通訊協定符合法律和安全標準,以及與醫療產品註冊相關的各個方面的管理。醫療保健和製藥領域的監管環境複雜且快速發展。醫療事務外包提供者提供監管諮詢和法律代表,以協助公司解釋和遵守管理這些行業的嚴格法規。這些服務包括監管策略、風險管理、合規評估以及與監管機構合作的建議。此外,我們還提供法律訴訟代理、代表公司進行談判以及公司與監管機構之間的持續溝通,以保持合規性並在出現法律問題時快速解決。複雜的溝通技巧對於清晰有效地傳達科學資料和監管訊息至關重要。監管文件準備醫療事務外包專業準備臨床試驗報告、監管備案和標準作業程式(SOP)等各種文件。這些服務確保所有材料均符合適當的準則並採用正確的格式以提交給監管機構。

業務模式:採用功能性服務模式,展現醫學寫作和資料分析重要領域的專業知識

醫療事務全方位服務外包是指由外部服務提供者管理企業整個醫療事務職能的綜合方式。希望利用第三方供應商的專業知識、基礎設施和全球影響力的公司選擇此模型。該模型涵蓋策略和營運方面,包括醫療資訊、醫療交流、醫藥學術專員(MSL) 活動、醫學教育和藥物安全檢測。職能外包涉及與外部合作夥伴簽訂合約來管理特定職能,而不是醫療事務部門的所有活動。這種業務模式使您能夠將專業知識集中在關鍵領域,例如科學寫作、資料分析和臨床試驗支持,同時管理公司內的其他職能。功能外包的模組化方法提供了彈性和擴充性,可滿足動態的市場需求,並使製藥和生物技術公司能夠有效地解決資源限制。部分或任務式的外包是一種選擇性方法,將醫療事務組合中的特定任務或計劃外包給專業供應商。該模型對於尋求管理短期需求、試點新舉措或處理需要內部不具備的特殊專業知識的業務的公司特別有用。這種形式的外包提供了高度的控制力和彈性,因為合約可以根據計劃要求和可用的內部資源擴大或縮小。

最終用戶:透過最終用戶之間的多樣化應用程式簡化營運成本

當生物技術和製藥公司需要臨床試驗、監管情況和市場准入的廣泛支援時,他們會轉向醫療事務外包服務。委外研發機構利用醫療事務外包來藥物安全檢測、監管支援和病患招募策略等專門業務,以擴大服務範圍並提高業務效率。作為重症加護提供者,醫院依靠醫療事務外包服務來簡化業務、改善病患治療效果並遵守醫療保健法規。外包使醫院能夠專注於患者護理,同時將臨床研究、醫療交流、繼續醫學教育等委託給專業提供者。醫療設備製造商透過外包醫療事務業務,走在產品核可和市場推廣的複雜道路上。療養院需要醫療事務外包服務來改善臨床實踐、患者照護標準並遵守醫療保健法規。

區域洞察

在美洲,尤其是美國和加拿大,製藥業務的合規性和透明度受到高度重視。這些地區的公司擴大將其醫療事務業務外包,以保持高水準的監管合規性並從外部專家那裡獲得策略見解。在醫藥產業高度發展的美洲,對於成熟的CRO和醫療事務服務提供者來說,有成熟的外包市場。亞太地區的特點是醫療保健市場多元化,各國製藥業處於不同的發展階段。由於本地企業的崛起和全球公司投資的增加,亞太地區的外包正在迅速擴張。臨床試驗數量的不斷增加、對專業醫療服務的需求不斷增加以及成本優勢極大地促進了亞太地區醫療事務外包的擴張。亞太地區的公司正在轉向外包,以獲得區域專業知識、擴大市場覆蓋範圍並滿足中國和印度等人口大國不斷成長的醫療保健需求。 EMEA(歐洲、中東和非洲)幅員遼闊,擁有多樣化的醫療保健系統和法規環境。醫療事務外包在歐洲已經很成熟,許多公司利用 CRO 和其他專業公司的服務,特別是在市場進入和健康經濟成果研究 (HEOR) 方面。中東和非洲是新興的外包市場,跨國公司正在尋求擴大在這些地區的業務。

FPNV定位矩陣

FPNV定位矩陣對於評估醫療事務外包市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。

市場佔有率分析

市場佔有率分析是一個綜合工具,可以對醫療事務外包市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。

本報告對以下幾個方面提供了寶貴的見解:

1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。

2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。

3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4.競爭評估與資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題:

1.醫務外包市場規模及預測如何?

2.在醫療事務外包市場的預測期間內,有哪些產品、細分市場、應用和領域需要考慮投資?

3. 醫療事務外包市場的技術趨勢和法規結構是什麼?

4.醫務外包市場主要廠商的市場佔有率如何?

5.進入醫事外包市場合適的形式或策略手段是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 擴大藥物管道並增加臨床資料的複雜性
      • 醫學出版品和教育內容的增加
      • 對實證醫學和價值醫療保健的需求不斷成長
    • 抑制因素
      • 與外包職能的溝通與品質相關的限制
    • 機會
      • 將人工智慧和機器學習技術融入醫療事務外包
      • 製藥公司與外包公司的策略合作
    • 任務
      • 對機密性和資料安全風險的擔憂
  • 市場區隔分析
    • 服務:更多採用醫療業務外包作為策略指導,以因應複雜的監管途徑
    • 業務模式:採用功能性服務模式以獲得醫學寫作和資料分析關鍵領域的有針對性的專業知識
    • 最終用戶:透過最終用戶的多樣化應用程式簡化營運成本
  • 市場擾動分析
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 價格分析
  • 技術分析
  • 專利分析
  • 貿易分析
  • 法規結構分析

第6章 醫療事務外包市場:依服務分類

  • 醫療通訊
  • 醫療資訊服務
  • 醫療監測
  • 醫藥學術專員
  • 醫學寫作和出版

第7章 醫療事務外包市場:依業務模式分類

  • 全方位服務外包
  • 功能外包
  • 部分/任務式的外包

第8章 醫療事務外包市場:依最終使用者分類

  • 生物技術和製藥公司
  • 合約研究組織
  • 醫院
  • 醫療設備公司
  • 療養院

第9章 美洲醫療事務外包市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太醫療事務外包市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東、非洲醫療事務外包市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
    • 全球醫療技術 CRO NAMSA 宣布與Terumo Corporation Aorta 建立策略外包合作夥伴關係
    • Millstone 醫療外包完成無塵室設施擴建
    • 工業和百時美施貴寶與 PRiME-R委託契約,在日本利用網路腫瘤學對Opdivo進行胃癌患者的臨床研究
  • 戰略分析和建議

第13章競爭產品組合

  • 主要企業簡介
  • 主要產品系列
Product Code: MRR-433C4187C541

[182 Pages Report] The Medical Affairs Outsourcing Market size was estimated at USD 9.78 billion in 2023 and expected to reach USD 11.16 billion in 2024, at a CAGR 14.59% to reach USD 25.39 billion by 2030.

Medical affairs is an essential function within the life sciences industry, encompassing a wide range of activities that bridge the gaps between clinical development, commercialization, and engagement with healthcare stakeholders. Medical affairs outsourcing refers to the practice of entrusting these activities, including medical writing, medical communications, publication planning, field medical engagement, medical information services, and health economics and outcomes research (HEOR) to external organizations with specialized expertise. As therapies become more complex, the demand for specialized medical affairs services grows. Companies entering new markets also seek local medical affairs support to navigate different regulatory landscapes. The robust pipeline of pharmaceutical and biotech companies broadens the potential for outsourcing services. However, challenges such as ensuring data security and maintaining quality control remain significant hurdles. While market players are focusing on improving service compliance and offerings, they are also developing tailored medical affairs strategies to support personalized therapies and are leveraging real-world evidence to demonstrate product value and inform clinical strategies. Digitalization and AI in medical affairs could also offer innovative outsourcing services.

KEY MARKET STATISTICS
Base Year [2023] USD 9.78 billion
Estimated Year [2024] USD 11.16 billion
Forecast Year [2030] USD 25.39 billion
CAGR (%) 14.59%

Services: Rising adoption of medical affair outsourcing for strategic guidance to navigate the intricate regulatory pathways

Organizations engaging in medical affairs outsourcing for clinical trial applications and product registrations can expect comprehensive support that spans the complete lifecycle of clinical research and product market entry. This includes the preparation and submission of documents required for the initiation of clinical trials, interfacing with regulatory authorities to ensure all trial protocols meet legal and safety standards, and managing the various aspects related to the registration of a medical product. The regulatory landscape of the healthcare and pharmaceutical sectors is complex and ever-evolving. Medical affairs outsourcing providers offering regulatory consulting and legal representation assist companies in interpreting and adhering to the stringent regulations that govern these industries. These services encompass advice on regulatory strategies, risk management, compliance assessments, and liaising with regulatory agencies. Additionally, they may provide representation during legal proceedings, negotiate on behalf of the company, and ensure consistent communication between businesses and regulatory bodies to maintain compliance and promptly address any legal issues that arise. Sophisticated communication skills are essential in conveying scientific data and regulatory information clearly and effectively. Medical affairs outsourcing for regulatory writing and publishing offers expert crafting of various documents, including clinical study reports, regulatory submission dossiers, and standard operating procedures (SOPs). These services ensure that all materials adhere to the appropriate guidelines and are suitably formatted for submission to regulatory agencies.

Operational Model: Adoption of functional service model to attain targeted expertise in vital areas of medical writing and data analysis

Full-service outsourcing within medical affairs refers to a comprehensive approach in which an external service provider manages the entirety of a company's medical affairs functions. This model is chosen by organizations seeking to leverage the specialized expertise, infrastructure, and global reach of third-party vendors. It encompasses the strategic and operational aspects, including medical information, medical communication, medical science liaison (MSL) activities, medical education, and pharmacovigilance. Functional outsourcing involves contracting external partners to manage specific functions within the medical affairs department rather than the full spectrum of activities. This operational model allows for targeted expertise in critical areas such as scientific writing, data analysis, or clinical trial support while maintaining control over other in-house capabilities. The modular approach of functional outsourcing offers flexibility and scalability, catering to dynamic market needs and enabling pharma or biotech companies to address resource constraints effectively. Partial or task-based outsourcing is a selective approach where specific tasks or projects within the medical affairs portfolio are outsourced to specialized vendors. This model is particularly useful for companies looking to manage short-term needs, pilot new initiatives, or handle tasks that require special expertise not available in-house. This form of outsourcing provides a high degree of control and flexibility, as companies can scale their engagements up or down based on the project requirements and available internal resources.

End User: Diverse applications across end-users for operational cost efficiency

Biotechnology and pharmaceutical companies are primary consumers of medical affairs outsourcing services to fulfill requirements of extensive support in navigating clinical trials, regulatory landscapes, and market access initiatives. Contract Research Organizations utilize medical affairs outsourcing for specialized tasks such as pharmacovigilance, regulatory support, and patient recruitment strategies to expand their service offerings and improve operational efficiencies. As critical care providers, hospitals engage medical affairs outsourcing services to streamline operations, improve patient outcomes, and ensure compliance with healthcare regulations. Outsourcing allows hospitals to focus on patient care while entrusting aspects of clinical research, medical communications, and continuing medical education to specialized providers. Medical device companies outsource medical affairs functions to navigate the complex pathways to product approval and market adoption. Nursing homes require medical affairs outsourcing services to improve clinical practices, patient care standards, and adherence to healthcare regulations.

Regional Insights

In the Americas, particularly in the United States and Canada, there is a significant emphasis on compliance and transparency in pharmaceutical operations. Firms in these regions often outsource medical affairs activities to maintain high levels of regulatory compliance and to gain strategic insights from external experts. With a highly developed pharmaceutical industry, the Americas generally show a mature outsourcing market characterized by the engagement of sophisticated CROs and medical affairs service providers. The APAC region is marked by its diverse healthcare markets, with countries at different stages of pharmaceutical industry development. Outsourcing in APAC is rapidly growing, driven by the emergence of local players and increasing investments by global companies. The rise in the number of clinical trials, growing demand for specialized medical services, and cost advantages are significant factors contributing to the expansion of Medical Affairs outsourcing in APAC. Companies in APAC turn to outsourcing to gain access to regional expertise, expand their market reach, and capitalize on the growing healthcare needs of populous countries, including China and India. EMEA encompasses a vast region with a wide variety of healthcare systems and regulatory environments. In Europe, medical affairs outsourcing is well-established, with many companies leveraging the services of CROs and other specialized firms, particularly for market access and health economics outcomes research (HEOR). The Middle East and Africa are emerging markets for outsourcing, with multinational companies exploring these regions for expansion.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Medical Affairs Outsourcing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Medical Affairs Outsourcing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Medical Affairs Outsourcing Market, highlighting leading vendors and their innovative profiles. These include Accenture PLC, Ashfield Healthcare Communications by Inizio, Biomapas Group, Charles River Laboratories International, Inc., Comprehend Systems, Inc. by Saama Technologies, Inc., Excelya, Freyr Solutions, Genpact, Groupe ProductLife S.A., ICON PLC, Indegene, Inc., Insuvia, IQVIA Holdings, Inc., JSS Medical Research Inc, Medpace Holdings, Inc., MMS Holdings Inc., PAREXEL International Corporation, Pharmalex by BlueReg, PPD, Inc. by Thermo Fischer Scientific Inc., ProPharma Group, SGS S.A., Syneos Health, Inc., The Medical Affairs Company, Wuxi Clinical Development, Inc., and Zeincro Group.

Market Segmentation & Coverage

This research report categorizes the Medical Affairs Outsourcing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Services
    • Medical Communications
    • Medical Information Services
    • Medical Monitoring
    • Medical Science Liaisons
    • Medical Writing & Publishing
  • Operational Model
    • Full-Service Outsourcing
    • Functional Outsourcing
    • Partial/Task-based Outsourcing
  • End-User
    • Biotechnology & Pharmaceutical Companies
    • Contract Research Organization
    • Hospitals
    • Medical Device Companies
    • Nursing Homes
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Medical Affairs Outsourcing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Medical Affairs Outsourcing Market?

3. What are the technology trends and regulatory frameworks in the Medical Affairs Outsourcing Market?

4. What is the market share of the leading vendors in the Medical Affairs Outsourcing Market?

5. Which modes and strategic moves are suitable for entering the Medical Affairs Outsourcing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Expansion of pharmaceutical pipeline and growing complexity of clinical data
      • 5.1.1.2. Increase in the volume of medical publications and educational content
      • 5.1.1.3. Rising demand for evidence-based medicine and value-based healthcare
    • 5.1.2. Restraints
      • 5.1.2.1. Limitations associated with communication and quality of outsourced functions
    • 5.1.3. Opportunities
      • 5.1.3.1. Inclusion of AI & ML technologies in medical affairs outsourcing
      • 5.1.3.2. Strategic collaborations between pharmaceutical companies and outsourcing firms
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with confidentiality and data security risks
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services: Rising adoption of medical affair outsourcing for strategic guidance to navigate the intricate regulatory pathways
    • 5.2.2. Operational Model: Adoption of functional service model to attain targeted expertise in vital areas of medical writing and data analysis
    • 5.2.3. End User: Diverse applications across end-users for operational cost efficiency
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Medical Affairs Outsourcing Market, by Services

  • 6.1. Introduction
  • 6.2. Medical Communications
  • 6.3. Medical Information Services
  • 6.4. Medical Monitoring
  • 6.5. Medical Science Liaisons
  • 6.6. Medical Writing & Publishing

7. Medical Affairs Outsourcing Market, by Operational Model

  • 7.1. Introduction
  • 7.2. Full-Service Outsourcing
  • 7.3. Functional Outsourcing
  • 7.4. Partial/Task-based Outsourcing

8. Medical Affairs Outsourcing Market, by End-User

  • 8.1. Introduction
  • 8.2. Biotechnology & Pharmaceutical Companies
  • 8.3. Contract Research Organization
  • 8.4. Hospitals
  • 8.5. Medical Device Companies
  • 8.6. Nursing Homes

9. Americas Medical Affairs Outsourcing Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Medical Affairs Outsourcing Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Medical Affairs Outsourcing Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Global MedTech CRO, NAMSA, Announces Strategic Outsourcing Partnership With Terumo Aortic
    • 12.3.2. Millstone Medical Outsourcing Completes Clean Room Facility Expansion
    • 12.3.3. ONO and Bristol Myers Squibb Sign Outsourcing Agreement with PRiME-R on Clinical Research of Opdivo in Patients with Gastric Cancer, utilizing CyberOncology in Japan
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio

LIST OF FIGURES

  • FIGURE 1. MEDICAL AFFAIRS OUTSOURCING MARKET RESEARCH PROCESS
  • FIGURE 2. MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. MEDICAL AFFAIRS OUTSOURCING MARKET DYNAMICS
  • FIGURE 7. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. MEDICAL AFFAIRS OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. MEDICAL AFFAIRS OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MEDICAL AFFAIRS OUTSOURCING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL COMMUNICATIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL INFORMATION SERVICES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL INFORMATION SERVICES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL MONITORING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL MONITORING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL SCIENCE LIAISONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL SCIENCE LIAISONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING & PUBLISHING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL WRITING & PUBLISHING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FULL-SERVICE OUTSOURCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FULL-SERVICE OUTSOURCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL OUTSOURCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY FUNCTIONAL OUTSOURCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PARTIAL/TASK-BASED OUTSOURCING, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY PARTIAL/TASK-BASED OUTSOURCING, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NURSING HOMES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 38. GLOBAL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY NURSING HOMES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 45. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 46. AMERICAS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 51. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 52. ARGENTINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 57. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 58. BRAZIL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 63. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 64. CANADA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 69. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 70. MEXICO MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 77. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 78. UNITED STATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 92. AUSTRALIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 97. CHINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 98. CHINA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 103. INDIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 104. INDIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 109. INDONESIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 110. INDONESIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 115. JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 116. JAPAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 121. MALAYSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 122. MALAYSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 127. PHILIPPINES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 128. PHILIPPINES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 133. SINGAPORE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 134. SINGAPORE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 139. SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 140. SOUTH KOREA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 145. TAIWAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 146. TAIWAN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 151. THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 152. THAILAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 157. VIETNAM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 158. VIETNAM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 171. DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 172. DENMARK MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 177. EGYPT MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 178. EGYPT MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 183. FINLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 184. FINLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 189. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 190. FRANCE MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 195. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 196. GERMANY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 201. ISRAEL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 202. ISRAEL MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 207. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 208. ITALY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 213. NETHERLANDS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 214. NETHERLANDS MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 219. NIGERIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 220. NIGERIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 225. NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 226. NORWAY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 231. POLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 232. POLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 237. QATAR MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 238. QATAR MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 243. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 244. RUSSIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 249. SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 250. SAUDI ARABIA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 256. SOUTH AFRICA MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 261. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 262. SPAIN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 267. SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 268. SWEDEN MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 273. SWITZERLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 274. SWITZERLAND MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 279. TURKEY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 280. TURKEY MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED ARAB EMIRATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED ARAB EMIRATES MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY SERVICES, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY OPERATIONAL MODEL, 2024-2030 (USD MILLION)
  • TABLE 291. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 292. UNITED KINGDOM MEDICAL AFFAIRS OUTSOURCING MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 293. MEDICAL AFFAIRS OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 294. MEDICAL AFFAIRS OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2023